Annual Accounts Payable
$3.98 M
+$2.64 M+197.09%
31 March 2022
Summary:
Sio Gene Therapies annual accounts payable is currently $3.98 million, with the most recent change of +$2.64 million (+197.09%) on 31 March 2022. During the last 3 years, it has risen by +$2.64 million (+197.09%).SIOX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$201.00 K
-$1.76 M-89.76%
31 December 2022
Summary:
Sio Gene Therapies quarterly accounts payable is currently $201.00 thousand, with the most recent change of -$1.76 million (-89.76%) on 31 December 2022.SIOX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +197.1% | -97.0% |
| 5 y5 years | +134.6% | -42.1% |
SIOX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -53.4% | -97.9% |
Sio Gene Therapies Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $201.00 K(-89.8%) |
| Sept 2022 | - | $1.96 M(-12.4%) |
| June 2022 | - | $2.24 M(-43.8%) |
| Mar 2022 | $3.98 M(+197.1%) | $3.98 M(-39.7%) |
| Dec 2021 | - | $6.61 M(+147.3%) |
| Sept 2021 | - | $2.67 M(+185.3%) |
| June 2021 | - | $937.00 K(-30.1%) |
| Mar 2021 | $1.34 M(-69.6%) | $1.34 M(+35.9%) |
| Dec 2020 | - | $987.00 K(-54.6%) |
| Sept 2020 | - | $2.17 M(-26.9%) |
| June 2020 | - | $2.97 M(-32.7%) |
| Mar 2020 | $4.41 M(+159.8%) | $4.41 M(+1171.5%) |
| Dec 2019 | - | $347.00 K(-77.9%) |
| Sept 2019 | - | $1.57 M(-45.9%) |
| June 2019 | - | $2.90 M(+70.6%) |
| Mar 2019 | $1.70 M | $1.70 M(+66.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | - | $1.02 M(-44.0%) |
| Sept 2018 | - | $1.82 M(+27.0%) |
| June 2018 | - | $1.43 M(-63.8%) |
| Mar 2018 | $3.95 M(-53.8%) | $3.95 M(+282.7%) |
| Dec 2017 | - | $1.03 M(-63.9%) |
| Sept 2017 | - | $2.86 M(-66.5%) |
| June 2017 | - | $8.55 M(-0.0%) |
| Mar 2017 | $8.55 M(+1274.8%) | $8.55 M(-7.6%) |
| Dec 2016 | - | $9.25 M(-2.7%) |
| Sept 2016 | - | $9.51 M(+234.5%) |
| June 2016 | - | $2.84 M(+357.1%) |
| Mar 2016 | $622.00 K(+54.3%) | $622.00 K(-82.5%) |
| Dec 2015 | - | $3.56 M(+410.2%) |
| Sept 2015 | - | $697.00 K(-7.8%) |
| June 2015 | - | $756.00 K |
| Mar 2015 | $403.00 K | - |
FAQ
- What is Sio Gene Therapies annual accounts payable?
- What is the all time high annual accounts payable for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly accounts payable?
- What is the all time high quarterly accounts payable for Sio Gene Therapies?
What is Sio Gene Therapies annual accounts payable?
The current annual accounts payable of SIOX is $3.98 M
What is the all time high annual accounts payable for Sio Gene Therapies?
Sio Gene Therapies all-time high annual accounts payable is $8.55 M
What is Sio Gene Therapies quarterly accounts payable?
The current quarterly accounts payable of SIOX is $201.00 K
What is the all time high quarterly accounts payable for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly accounts payable is $9.51 M